LDHAL6DP

Across TCGA pan-cancer cohorts, LDHAL6DP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LDHAL6DP’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LDHAL6DP RNA is repressed in tumor relative to normal tissue. In most cancer types LDHAL6DP is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

LIHC are the cancer types where LDHAL6DP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LDHAL6DP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	All	−0.022	.030	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

LDHAL6DP–LIHC

Open the LIHC breakdown →